Koninklijke Philips NV has announced a new partnership with Anumana, enhancing its ECG ecosystem by integrating third-party AI solutions to support clinical decision-making in cardiac care. Through the Philips ECG AI Marketplace, the collaboration aims to improve access to early cardiovascular disease detection and care by providing cardiac care teams with AI-enabled diagnostic tools. This partnership will enable U.S. hospitals to integrate validated algorithms into their workflow, reducing the time clinicians spend reviewing ECG results and expediting patient diagnoses. Anumana's AI algorithms, including those for LEF detection, have been extensively validated and will be available on Philips' trusted platform, reflecting a commitment to improving outcomes for patients at risk of heart failure.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。